C. Marras

发表

Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study

E. Pérez-Pampín, A. Balsa, J. Tovar Beltrán, 2015, Rheumatology International.

Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

P. Carreira, J. Rosas, A. Fernández-Nebro, 2015, Medicine.

Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review.

L. Carmona, C. Marras, L. Cea‐Calvo, 2021, Immunotherapy.

Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

A. Fernández-Nebro, M. Rodríguez-Gómez, C. Marras, 2019, Lupus.

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)

J. Andreu, J. Rosas, A. Fernández-Nebro, 2016, Medicine.

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.

P. Carreira, J. Andreu, I. Millán, 2017, Reumatologia clinica.

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature

P. Carreira, J. Andreu, I. Millán, 2019, Reumatología Clínica (English Edition).

Efficacy of Tocilizumab in Conventional Treatment–Refractory Adult‐Onset Still's Disease: Multicenter Retrospective Open‐Label Study of Thirty‐Four Patients

S. Castañeda, C. Marras, J. Llobet, 2014, Arthritis & rheumatology.

Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain

P. Carreira, S. Manrique-Arija, A. Fernández-Nebro, 2020 .

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study.

M. González-Gay, L. Rodríguez-Rodríguez, J. Nolla, 2017, Reumatologia clinica.

Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study

M. González-Gay, L. Rodríguez-Rodríguez, J. Nolla, 2019, Reumatología Clínica (English Edition).

Delayed examination of synovial fluid by ordinary and polarised light microscopy to detect and identify crystals

C. Marras, L. Linares, J. Gálvez, 2002, Annals of the rheumatic diseases.

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

M. Canteras-Jordana, C. Marras, J. Martín-Fernández, 2016, Pharmacogenetics and genomics.

Évaluation diagnostique et critères de classification du syndrome de Sjögren

C. Marras, L. Linares, J. Gálvez, 2009 .

Diagnostic evaluation and classification criteria in Sjögren's Syndrome.

C. Marras, L. Linares, J. Gálvez, 2009, Joint, bone, spine : revue du rhumatisme.

Pancreatitis associated with pleural-mediastinal pseudocyst, panniculitis and polyarthritis

J. García-Estañ, C. Marras, C. Garre, 2005, Clinical Rheumatology.

Infliximab-Induced Vitiligo

C. Marras, J. Martínez-Escribano, M. Ramírez-Hernández, 2004, Dermatology.

Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER).

P. Carreira, J. Rosas, A. Fernández-Nebro, 2020, Rheumatology.

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

J. Andreu, A. Fernández-Nebro, M. Rodríguez-Gómez, 2017, Seminars in arthritis and rheumatism.

The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern

L. Carmona, C. Marras, E. Raya, 2018, Rheumatology International.

Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study

L. Carmona, C. Marras, J. Calvo-Alén, 2017, Rheumatology International.

Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).

J. Andreu, C. Marras, J. Calvo-Alén, 2017, Clinical and experimental rheumatology.

Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).

C. Marras, J. Calvo-Alén, R. Blanco, 2019, Seminars in arthritis and rheumatism.

Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus.

J. Andreu, M. Rodríguez-Gómez, C. Marras, 2016, Clinical and experimental rheumatology.

FRI0197 Adherence, satisfaction and fulfillment of expectations of patients with rheumatoid arthritis treated with subcutaneous biologicals. arco study

J. Rosas, C. Marras, J. Calvo-Alén, 2017 .

A Composite Indicator to Assess the Quality of Care in the Management of Patients With Rheumatoid Arthritis in Outpatient Rheumatology Clinics

R. Sanmartí, C. Marras, F. Sánchez-Alonso, 2019, Reumatología Clínica (English Edition).

A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics.

R. Sanmartí, C. Marras, F. Sánchez-Alonso, 2019, Reumatologia clinica.

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

J. Andreu, A. Fernández-Nebro, C. Marras, 2017, Seminars in arthritis and rheumatism.

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

L. Carmona, J. Rosas, C. Marras, 2017, Clinical and experimental rheumatology.

The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern

C. Marras, T. Salman-Monte, M. Arteaga, 2018, Rheumatology International.